Form4insider filings, from the source

SEC Form 4 · accession 0001144204-18-029229

SOLENO THERAPEUTICS INC · SLNO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
May 14, 2018
Accepted (ET)
May 16, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.001 per shareF1,F4,F5May 14, 2018P40,100$1.7916A1,668,323ISee footnote
Common Stock, par value $0.001 per shareF2,F4,F5May 14, 2018P8,426$1.7916A551,167ISee footnote
Common Stock, par value $0.001 per shareF1,F4,F5May 15, 2018P1,218$1.9276A1,669,541ISee footnote
Common Stock, par value $0.001 per shareF2,F4,F5May 15, 2018P256$1.9276A551,423ISee footnote
Common Stock, par value $0.001 per shareF3,F4,F5holding———217,096ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses